Clinical Trials on Myasthenia Gravis, Autoimmune, Experimental

Total 453 results

Jesús María Villar del Moral

Completed

Preoperative Preparation With Lugol Solution in Patients With Graves-Basedow Disease. (LIGRADIS)

Hyperthyroidism, Autoimmune

Spain
Jagiellonian University

Completed

Subtotal Versus Total Thyroidectomy for Graves' Disease

Goiter | Thyroid

Poland
Hospital Clinico Universitario de Santiago
Fundación Ramón Domínguez

Completed

Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease) (GRC)

Thyroid Eye Disease | Thyroid Associated Ophthalmopathies | Graves´ Ophthalmopathy

Spain
University of Roma La Sapienza

Completed

Parathyroid Reimplantation in Forearm Subcutaneous Tissue During Thyroidectomy: a Simple Way to Avoid Ipoparathyroidism and Evaluate Graft Function

Thyroid Carcinoma | Thyroid Goiter | Multinodular Goiter | Graves Diseases

Italy
Silkiss, Rona Z., M.D., FACS
Lauer, Simeon, M.D.; Reier, Alice M.D.; Coleman, Morton M.D.

Completed

Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy

Thyroid Related Orbitopathy | Graves' Dysthyroid Ophthalmopathy

United States
Sun Yat-sen University

Recruiting

Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy

Immune System Diseases | Autoimmune Diseases | Endocrine System Diseases | Thyroid Diseases | Eye Diseases, Hereditary | Graves Ophthalmopathy | Graves Disease | Hyperthyroidism | Thyroid-associated Ophthalmopathy

China
Assiut University

Not yet recruiting

Bone Mineral Density in Children With Graves' Disease

Bone Density, Low | Bone Mineral Density in Children With Graves' Disease
Lassen Therapeutics Inc.

Recruiting

A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease

Eye Diseases | Endocrine System Diseases | Thyroid Eye Disease | Graves Ophthalmopathy | Orbital Diseases | Thyroid Associated Ophthalmopathy | Graves Orbitopathy | Proptosis

United States, United Kingdom, Spain
Worg Biotherapeutics Inc.

Recruiting

Phase 2 Study to Assess Efficacy & Safety of WP1302 Prevent Relapse of MMI w/Draw in Subj. w/ Graves' dz

Graves Disease

United States
Xiao-Ming Mao

Completed

Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone

Graves' Disease
Xiao-Ming Mao
National Natural Science Foundation of China

Not yet recruiting

Graves' Disease Induced by Epstein-Barr Virus Lytic Reactivation

Graves Disease | Epstein-Barr Virus | Graves' Disease in Remission

China
National Center for Research Resources (NCRR)
Juvenile Diabetes Research Foundation

Unknown

hOKT3gamma1 (Ala-Ala) for the Prevention of Human Islet Allograft Failure

Islets of Langerhans Transplantation | Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus, Experimental | Transplantation, Homologous

United States
Vastra Gotaland Region

Recruiting

Course for Brain Fatigue After Graves' Disease Controlled Study (MF-Course)

Graves Disease

Sweden
Istituto Auxologico Italiano

Recruiting

Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery (TIROVASC)

Graves Disease | Hyperthyroidism | Thyroid Cancer | Multinodular Goiter | Plummer Disease | Euthyroid Goiter | Basedow Disease

Italy
Centre Hospitalier Universitaire, Amiens

Completed

Prevalence of Circulating Parvovirus Genome in Recently Diagnosed Graves' Disease: a Case-control Study (GPCBasedow)

Graves Disease

France
Sling Therapeutics, Inc.

Recruiting

A Phase 2b Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Eye Diseases | Endocrine System Diseases | Thyroid Diseases | Thyroid Eye Disease | Graves Ophthalmopathy | Exophthalmos | Orbital Diseases | Thyroid Associated Ophthalmopathy | Graves Orbitopathy | Proptosis | IGF1R | Hashimoto

United States
Sling Therapeutics, Inc.

Active, not recruiting

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) (LIDS)

Eye Diseases | Endocrine System Diseases | Thyroid Diseases | Thyroid Eye Disease | Graves Ophthalmopathy | Exophthalmos | Orbital Diseases | Thyroid Associated Ophthalmopathy | Graves Orbitopathy | Proptosis | IGF1R | Hashimoto

United States, Spain, Italy, United Kingdom, Canada
Vastra Gotaland Region

Recruiting

Validating Immunological Markers Associated With Mental Fatigue in Graves' Disease

Mental Fatigue | Graves Disease

Sweden
Medical University of Warsaw

Completed

Impact of Intravenous Methylprednisolone Treatment on Blood Pressure

Heart Failure | Hypertension | Graves Ophthalmopathy | Graves Disease | Blood Pressure
University of Pisa

Completed

Graves' Orbitopathy and Hypercholesterolemia (GOCol)

Hypercholesterolemia | Graves' Ophthalmopathy

Italy
LMU Klinikum

Recruiting

The Risk of Falls Index for Patients With Neuromuscular Disorders

Myasthenia Gravis | Myotonic Dystrophy | Inclusion Body Myositis | Facioscapulohumeral Muscular Dystrophies | The Falls Efficacy Scale International | The Morse Fall Scale

Germany
Vastra Gotaland Region

Recruiting

Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease

Autoimmune Diseases | Thyroid Diseases | Mental Fatigue | Graves Ophthalmopathy | Graves Disease

Sweden
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...
Azienda Ospedaliero, Universitaria Pisana; Istituto Auxologico Italiano; Azienda... and other collaborators

Recruiting

Tocilizumab in Active Moderate-severe Graves' Orbitopathy (TOGO)

Graves Ophthalmopathy

Italy
University of Pisa

Not yet recruiting

Sirolimus for Graves' Orbitopathy (GO) (SIRGO)

Graves Ophthalmopathy

Italy
University of Pisa

Completed

Sirolimus in Graves' Orbitopathy (RETROSIRGO)

Graves Ophthalmopathy

Italy
Kyushu University

Completed

Effective Iodide Therapy for Untreated Patients With Graves' Hyperthyroidism Avoiding Thionamide Drugs With Many Side Effects

Graves Disease
GlaxoSmithKline

Terminated

A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease

Graves Ophthalmopathy

United Kingdom
University of Pisa

Completed

T and B Cells in Graves' Orbitopathy (LYMPHGO)

Graves Ophthalmopathy
University of British Columbia

Unknown

Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease (CRISEPTED)

Graves Ophthalmopathy
University of Sao Paulo

Unknown

Comparison Study Between Two Techniques for Correction of Upper Lid Retraction in Patients With Grave's Orbitopathy

Graves Ophthalmopathy

Brazil
Singapore National Eye Centre
International Stem Cell Forum

Completed

Thyroid Treatment Trial

Graves Ophthalmopathy

Singapore
Johns Hopkins University

Recruiting

Bimatoprost as a Treatment for Graves' Orbitopathy

Graves Ophthalmopathy

United States
University of Toronto
Allergan

Withdrawn

Use of Botox in the Management of Thyroid Related Upper Eyelid Retraction

Graves Ophthalmopathy

Canada
First Affiliated Hospital Xi'an Jiaotong University
Nanjing First Hospital, Nanjing Medical University; Beijing Tongren Hospital; People's Hospital of Xinjiang Uygur Autonomous Region and other collaborators

Not yet recruiting

Rapamycin Plus Methylprednisolone Versus Methylprednisolone Alone in Active, Moderate-to-severe Graves' Orbitopathy.

Graves Ophthalmopathy

China
National Taiwan University Hospital

Recruiting

Hydroxychloroquine in Mild Graves' Orbitopathy

Graves Ophthalmopathy

Taiwan
Medical University of Sofia

Completed

Comparison of the Effectiveness of Two Glucocorticoid Regimens for Treatment of Graves' Orbitopathy

Graves Ophthalmopathy

Bulgaria
Torben Harsløf
Odense University Hospital

Active, not recruiting

Glucocorticoids and Bone in Graves' Ophthalmopathy

Graves Ophthalmopathy

Denmark
University of Pisa

Completed

Genetics and Epigenetics of Graves' Orbitopathy (GeneGO)

Graves Ophthalmopathy

Italy
National Taiwan University Hospital

Unknown

Observing the Relationship of Fibroblast Growth Factor and Fibroblast in Thyroid Eye Disease (TED)

Graves Ophthalmopathy

Taiwan
University of Medicine and Pharmacy at Ho Chi Minh...

Completed

TSI and Its Relationship With Graves' Disease Relapse

Graves Disease | Immunoglobulin | Anti-Thyroid Antibodies Disorder

Vietnam
Dartmouth-Hitchcock Medical Center

Completed

Neurology Inpatient Clinical Education Trial

Multiple Sclerosis | Encephalitis | Seizures | Headache | Myasthenia Gravis | Meningitis | Parkinsonism | Spondylosis | Guillain-Barre Syndrome | Vestibular Disorder | Normal Pressure Hydrocephalus

United States
All India Institute of Medical Sciences, Bhubaneswar

Not yet recruiting

Study on Efficacy of Add on Selenium in Mild-to-moderate Graves Ophthalmopathy

Thyroid Eye Disease | Graves Ophthalmopathy

India
Janjira Petsuksiri
Mahidol University

Not yet recruiting

Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial)

Thyroid Associated Ophthalmopathy

Thailand
Sun Yat-sen University

Recruiting

Study of Therapeutic Value of Periorbital Injection of Glucocorticoid in Mild TAO

Thyroid Associated Ophthalmopathy

China
University of Pisa

Not yet recruiting

A Trial to Evaluate the Efficacy of Orbital Radiotherapy in Graves' Orbitopathy (ORGO)

Thyroid Associated Ophthalmopathy
Cairo University

Completed

Thyroid Associated Orbitopathy Treatment by Methotrexate Against Triamcinolone Periocular Injections (TOMATO)

Thyroid Associated Orbitopathy

Egypt
Sun Yat-sen University

Unknown

Natural History and Risk Factors of TAO

Thyroid Associated Ophthalmopathy

China
HaEmek Medical Center, Israel

Unknown

Local Triamcinolone Injection in Active Thyroid Orbitopathy

Thyroid Disease
Göteborg University
Sahlgrenska University Hospital, Sweden

Active, not recruiting

Rituximab (RTX) Therapy in Patients With Active TAO

Ophthalmopathy, Thyroid-Associated

Sweden
Instituto de Oftalmología Fundación Conde de Valenciana

Completed

Oral Supplementation With Selenium in Patients With Mild Thyroid Orbitopathy

Thyroid Orbitopathy

Clinical Trials on Myasthenia Gravis, Autoimmune, Experimental

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations